Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate and Duloxetine for Cocaine Use Disorder
NCT02700711Phase 1Completed
- Sponsor
- University of Kentucky
- Start
- Feb 2016
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of methylphenidate and duloxetine in cocaine use disorder (CUD) (2 arms), sponsored by University of Kentucky. Primary endpoint: Number of Cocaine Positive Urines at 6 weeks. Started Feb 2016; status: completed.
02
Drugs
methylphenidateduloxetine
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT02700711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02700711.